Evidence map›Paper›PMID 36069552›Full record

ArticleJournal of virology2022

The Amino Acid at Position 95 in the Matrix Protein of Rabies Virus Is Involved in Antiviral Stress Granule Formation in Infected Cells.

Isshu Kojima, Koji Onomoto, Wenjie Zuo, Makoto Ozawa, Kosuke Okuya, Kiyotada Naitou, Fumiki Izumi, Misuzu Okajima, Takuro Fujiwara, Naoto Ito and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Rabies Virus Infection Causes Pyroptosis of Neuronal Cells.International journal of molecular sciences · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Isshu KojimaJoint Graduate School of Veterinary Medicine, Kagoshima Universitygrid.258333.c, Kagoshima, Japan.
Koji OnomotoDivision of Molecular Immunology, Medical Mycology Research Center, Chiba Universitygrid.136304.3, Chiba, Japan.
Wenjie ZuoDivision of Integrated Life Science, Graduate School of Biostudies, Kyoto Universitygrid.258799.8, Kyoto, Japan.
Makoto OzawaJoint Graduate School of Veterinary Medicine, Kagoshima Universitygrid.258333.c, Kagoshima, Japan.ORCID 0000-0002-7731-5321
Kosuke OkuyaJoint Graduate School of Veterinary Medicine, Kagoshima Universitygrid.258333.c, Kagoshima, Japan.
Kiyotada NaitouDepartment of Basic Veterinary Science, Joint Faculty of Veterinary Medicine, Kagoshima Universitygrid.258333.c, Kagoshima, Japan.
Fumiki IzumiJoint Graduate School of Veterinary Sciences, Gifu Universitygrid.256342.4, Gifu, Japan.
Misuzu OkajimaJoint Graduate School of Veterinary Sciences, Gifu Universitygrid.256342.4, Gifu, Japan.
Takuro FujiwaraLaboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu Universitygrid.256342.4, Gifu, Japan.
Naoto ItoJoint Graduate School of Veterinary Sciences, Gifu Universitygrid.256342.4, Gifu, Japan.
Mitsutoshi YoneyamaDivision of Molecular Immunology, Medical Mycology Research Center, Chiba Universitygrid.136304.3, Chiba, Japan.
Kentaro YamadaLaboratory of Veterinary Public Health, Department of Veterinary Science, Faculty of Agriculture, University of Miyazakigrid.410849.0, Miyazaki, Japan.
Akira NishizonoDepartment of Microbiology, Faculty of Medicine, Oita Universitygrid.412334.3, Yufu, Japan.
Makoto SugiyamaLaboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu Universitygrid.256342.4, Gifu, Japan.
Takashi FujitaDivision of Integrated Life Science, Graduate School of Biostudies, Kyoto Universitygrid.258799.8, Kyoto, Japan.ORCID 0000-0001-9961-0535
Tatsunori MasataniJoint Graduate School of Veterinary Sciences, Gifu Universitygrid.256342.4, Gifu, Japan.ORCID 0000-0002-2347-4079
Gifu University · JPKagoshima University · JPChiba University · JPKyoto University · JPOita University · JPUniversity of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stress granules (SGs) are dynamic structures that store cytosolic messenger ribonucleoproteins. SGs have recently been shown to serve as a platform for activating antiviral innate immunity; however, several pathogenic viruses suppress SG formation to evade innate immunity. In this study, we investigated the relationship between rabies virus (RABV) virulence and SG formation, using viral strains with different levels of virulence. We found that the virulent Nishigahara strain did not induce SG formation, but its avirulent offshoot, the Ni-CE strain, strongly induced SG formation. Furthermore, we demonstrated that the amino acid at position 95 in the RABV matrix protein (M95), a pathogenic determinant for the Nishigahara strain, plays a key role in inhibiting SG formation, followed by protein kinase R (PKR)-dependent phosphorylation of the α subunit of eukaryotic initiation factor 2α (eIF2α). M95 was also implicated in the accumulation of RIG-I, a viral RNA sensor protein, in SGs and in the subsequent acceleration of interferon induction. Taken together, our findings strongly suggest that M95-related inhibition of SG formation contributes to the pathogenesis of RABV by allowing the virus to evade the innate immune responses of the host.

Indexed as

Rabies virusStress GranulesViral Matrix ProteinsAmino AcidsAnimalsEukaryotic Initiation Factor-2HumansInterferonsProtein KinasesRibonucleoproteinsRNA, ViralViral ProteinsAmino AcidsEukaryotic Initiation Factor-2InterferonsProtein KinasesRibonucleoproteinsRNA, ViralViral Matrix ProteinsViral Proteinsinterferonsrabiesstress granules

Identifiers

PMID36069552
PMCPMC9517722
OpenAlexW4294916197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.